Carl Zeiss Meditec’s revenue declined 2.9 percent year-over-year to €1,553.7 million in the first nine months of fiscal year 2025/26, though the topline was flat on a constant-currency basis, an improvement from the negative currency-adjusted trend seen at the half-year mark. Adjusted EBITA margin fell to 8.0 percent from 11.1 ...

Buying a membership today will give you:
To continue reading this article register now.